azelate / cupric oxide / folic acid / niacinamide / pyridoxine / zinc oxide Oral Tablet
RxNorm concept 1145108, clinical dose form (scdf).
- RxCUI
- 1145108
- Term type
- Clinical dose form (SCDF)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1145108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Oral Tablet (DF, has dose form)
- folic acid (IN, has ingredient)
- niacinamide (IN, has ingredient)
- zinc oxide (IN, has ingredient)
- cupric oxide (IN, has ingredient)
- azelate (IN, has ingredient)
- pyridoxine (IN, has ingredient)
- azelate / cupric oxide / folic acid / niacinamide / pyridoxine / zinc oxide Oral Tablet [NicAzel] (SBDF, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1145108 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1145108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1145108. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.